In comments to CMS, NACDS says weakening of state access standards is flawed policymaking, and threatens to harm patient health and increase Medicaid costs
Washington State’s inaccurate justification for reimbursing pharmacies below cost—lower than any state in the country—threatens patient access to care.
NACDS, WSPA, and NCPA applaud action by the federal Centers for Medicare & Medicaid Services (CMS) to reject Washington State’s below-cost and lowest-in-the-nation Medicaid pharmacy dispensing fees.
NACDS has submitted comments to Health and Human Services Secretary Alex Azar in response to the agency’s request-for-information on drug-pricing public policy issues.
Three pharmacy associations filed an important legal brief this week with the Washington State Court of Appeals, challenging the state’s refusal to reimburse community pharmacies for the costs of providing care and services to disadvantaged Medicaid patients.
NACDS attended a Senate hearing on the opioid epidemic where NACDS-backed policies--e-prescribing and prescription drug monitoring programs--were discussed as successful strategies.